Scarica l'app Stockscreener
10.01
0.00%
0.00
Precedente Chiudi:
$10.01
Aprire:
$10.01
Volume 24 ore:
215.58K
Relative Volume:
2.04
Capitalizzazione di mercato:
$637.64M
Reddito:
-
Utile/perdita netta:
$4.19M
Rapporto P/E:
154.00
EPS:
0.065
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.30%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.00
$10.02
Intervallo di 1 settimana:
$10.00
$10.02
Portata 52W:
$9.87
$10.02
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Nome
Drugs Made In America Acquisition Ii Corp
Settore
Industria
Telefono
954-870-3104
Indirizzo
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, BCSS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.64M | 0 | 4.19M | 0 | 0.065 |
LION
Lionsgate Studios Corp
|
12.20 | 3.55B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.83 | 2.76B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
13.74 | 692.44M | 11.20M | -19.19M | -23.24M | -0.7527 |
BCSS
Bain Capital Gss Investment Corp
|
10.16 | 593.93M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Ii Corp Borsa (DMII) Ultime notizie
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Beng Kuang Marine Receives SGX Approval for Listing of 57 Million New Shares for Asian Sealand Acquisition - Minichart
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
Leadership Compensation Aligned With Future Business Combination - TipRanks
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
DRUMMOND VEN: Performance & Quotes, MACK Stock Price on Toronto S.E. Exchange - marketscreener.com
DMIIR Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
AlphaTON Capital Corp. (ALP) - Minichart
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
Centiel AG: Shareholders Board Members Managers and Company Profile | CH0024666528 - marketscreener.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành
Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan
Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition 10-K: $0 revenue, $5.94M net income, ($0.28M) net loss - TradingView
Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
Drugs Made In America Acquisition Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
MRLN|Inflection Point Acquisition IV Ord Shs Class A|Price:13.660|Chg%:0.08 - TradingKey
Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat
Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart
Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka
Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com
Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView
Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets
De-SPAC LOI values Power Analytics at $1.0B with DMAA (NASDAQ: DMAA) - Stock Titan
Proem Acquisition Corp I: Performance & Quotes, PAAC Stock Price on Nasdaq Exchange - marketscreener.com
Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com
Willow Lane Acquisition Corp. II: Performance & Quotes, WLII Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition Ii Corp Azioni (DMII) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.18%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):